Since 2013, the ITOMIC triple negative breast cancer trial has been on the leading edge of where cancer advances are going... equipping physicians and patients with personalized information about how to treat their cancer. To date, 31 patients have been enrolled in the trial, 28 of whom are South Sound CARE patients. The ITOMIC trial has opened up an avenue for this innovative approach for patients with an incurable form of breast cancer. The study is getting international attention in scientific articles... and now in the New York Times.
Related Articles
Launching a new business or expanding into a new space is a major milestone, and we’re proud to help bring those visions to life. Over the past year,...
At The Rush Companies, our tagline, "Building an Exceptional Future, Together," embodies our genuine dedication to creating a better future for...
Giving back continues to be an important part of who we are at Rush. In 2025, our team once again came together to support a wide range of...